BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue ...

In a report released today, Terence Flynn from Morgan Stanley assigned a Hold rating on Moderna (MRNA – Research Report), with a price target ...

The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

There is a distrust of, and dislike of mRNA vaccines among some people. Though the risk of death from Covid still exceeds ...

Discover the origins, impact, and future of COVID-19, the virus that caused a pandemic that reshaped public opinion and exposed global health inequities.

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.